Krsnaa Diagnostics (NSE:KRSNAA) Change In Receivables: ₹0 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:KRSNAA Krsnaa Diagnostics Ltd NSE:KRSNAA
72 GF Score
Price ₹550.05
GF Value ₹924.23
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Krsnaa Diagnostics Change In Receivables?

Krsnaa Diagnostics NSE:KRSNAA -2.54% 72 Change In Receivables is ₹0 Mil as of Jun. 2026. GuruFocus rates NSE:KRSNAA with a GF Score™ of 72/100 and a GF Value™ of ₹924.23 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Krsnaa Diagnostics's change in receivables for the quarter that ended in Jun. 2026 was ₹0 Mil. It means Krsnaa Diagnostics's Accounts Receivable stayed the same from Mar. 2026 to Jun. 2026 .

Krsnaa Diagnostics's change in receivables for the fiscal year that ended in Mar. 2026 was ₹-184 Mil. It means Krsnaa Diagnostics's Accounts Receivable increased by ₹184 Mil from Mar. 2025 to Mar. 2026 .

Krsnaa Diagnostics's Accounts Receivable for the quarter that ended in Jun. 2026 was ₹0 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Krsnaa Diagnostics's Days Sales Outstanding for the three months ended in Jun. 2026 was 0.00.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Krsnaa Diagnostics's liquidation value for the three months ended in Jun. 2026 was ₹0 Mil.

Krsnaa Diagnostics  (NSE:KRSNAA) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Krsnaa Diagnostics's Days Sales Outstanding for the quarter that ended in Jun. 2026 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0/2355.32*91
=0.00

2. In Ben Graham's calculation of liquidation value, Krsnaa Diagnostics's accounts receivable are only considered to be worth 75% of book value:

Krsnaa Diagnostics's liquidation value for the quarter that ended in Jun. 2026 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=0-0+0.75 * 0+0.5 * 0
=0

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Krsnaa Diagnostics Change In Receivables Related Terms

Krsnaa Diagnostics Change In Receivables Historical Data

* Premium members only.

The historical data trend for Krsnaa Diagnostics's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Krsnaa Diagnostics Change In Receivables Chart

Krsnaa Diagnostics Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Change In Receivables
Get a 7-Day Free Trial 160.33 -144.31 -1,035.49 -1,023.35 -183.77

Krsnaa Diagnostics Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:KRSNAA
72GF Score
Krsnaa Diagnostics Ltd NSE:KRSNAA
Change In Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Krsnaa Diagnostics Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of ₹0 Mil mean?
Krsnaa Diagnostics (NSE:KRSNAA) has a Change In Receivables of ₹0 Mil as of Jun. 2026. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Krsnaa Diagnostics and its competitors.
Is Krsnaa Diagnostics' Change In Receivables too high?
Krsnaa Diagnostics' current Change In Receivables is ₹0 Mil. Overall, Krsnaa Diagnostics has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Krsnaa Diagnostics' Change In Receivables compare to TMO and DHR?
Krsnaa Diagnostics' Change In Receivables of ₹0 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Medical Diagnostics & Research company?
A good Change In Receivables depends on the Medical Diagnostics & Research industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Krsnaa Diagnostics and its competitors. Krsnaa Diagnostics's current Change In Receivables is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Krsnaa Diagnostics stock overvalued right now?
Based on GuruFocus' analysis, Krsnaa Diagnostics (NSE:KRSNAA) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹924.23, compared to a current price of ₹550.05 — trading 40.5% below its estimated fair value. The current Change In Receivables is ₹0 Mil. Krsnaa Diagnostics' overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Krsnaa Diagnostics (NSE:KRSNAA), the current Change In Receivables is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Krsnaa Diagnostics (NSE:KRSNAA) Overvalued in 2026?

Based on GuruFocus' analysis, Krsnaa Diagnostics stock appears to be undervalued. The current stock price of ₹550.05 is trading 40.5% below its estimated GF Value™ of ₹924.23. GuruFocus considers Krsnaa Diagnostics to be Significantly Undervalued.

Key valuation signals for NSE:KRSNAA:

  • Change In Receivables: ₹0 Mil
  • GF Value™: ₹924.23 vs. price of ₹550.05 (40.5% below fair value)
  • GF Score™: 72/100 with 4 warning signs

No single metric tells the full story. See the NSE:KRSNAA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Krsnaa Diagnostics Business Description

Other Exchanges 543328:India
Address S.No. 243, A-Hissa No. 6, CTS No. 4519, 4519/1, Near Chinchwad Station, Chinchwad, Taluka - Haveli, Pune, MH, IND, 411 019
Krsnaa Diagnostics Ltd is a diagnostic services provider, both in Radiology and Pathology. It offers a wide range of diagnostic services such as imaging/radiology services, routine clinical laboratory tests, pathology, and tele-radiology services to private and public hospitals, medical colleges, and community health centres. The company's operations predominantly relate to providing Radiology and Pathology services for X Ray, CT Scan, MRI, Mammography, tele-reporting services, and all types of Blood and Urine investigations.
72GF Score

Get the complete analysis for NSE:KRSNAA

Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹550.05
Price
₹924.23
GF Value